LYNNETTE ATKINSON: Open Payments
NPI 1366870792 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 35 payments from 13 companies in 2025. Trend: 2023 $267 · 2024 $499 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $158 |
| Insmed, Inc. | 8 | $138 |
| Inspire Medical Systems, Inc. | 3 | $63 |
| Amgen Inc. | 2 | $48 |
| HARMONY BIOSCIENCES LLC | 1 | $46 |
| GENZYME CORPORATION | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Pulmonx Corporation | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Verona Pharma, Inc. | 1 | $28 |
Products named: Arikayce, NUCALA, INSPIRE, TEZSPIRE, WAKIX, DUPIXENT, OFEV, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
